Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Top-Ranking U.S. Military Official Defends Critical Race Theory: ‘I’ve Read Mao Tse-Tung. I’ve Read Karl Marx. I’ve Read Lenin. That Doesn’t Make Me A Communist’

Joint Chiefs of Staff Chair Mark Milley on Wednesday justified…
Read more

San Francisco Requires COVID-19 Vaccine For All City Employees

The city of San Francisco announced that they will require…
Read more

Elon Musk’s Satellite-Based Internet is Extremely Fast

In initial speed tests, Elon Musk's new Starlink internet…
Read more